TB

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This guide was developed to help advocacy, communication, and social mobilization (ACSM) programs at national and subnational levels strengthen routine monitoring and evaluation of tuberculosis ACSM activities.

This tool is designed to support the effective monitoring and evaluation (M&E) of tuberculosis (TB) control programs in refugee camps and other settings located in resource-poor areas.

This document revises previous WHO standard case definitions for TB and drug-resistant TB, the categories used to assign outcomes, and the standard reporting framework for TB.

This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership. The application contains the eight training modules which comprise the WMA's course on MDR-TB.

The US Agency for International Development (USAID) has reported to Congress on its international foreign assistance efforts to control tuberculosis (TB). Titled Leading and Leveraging, the report documents work completed the previous fiscal year.

The goal of the Global Fund (to eliminate AIDS, tuberculosis, and malaria) resonates powerfully with many young people and in response to frequent questions about how they could be involved, the Fund issued a Youth Guide directed especially to their interests. Silhouette illustrations make it racially universal and allow readers to project themselves into the images.

Dr. Kenneth Castro explains why it is important for people living with HIV to be tested for TB.

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.